Suppr超能文献

自身免疫性疾病发病机制中的Toll样受体

Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

作者信息

Mohammad Hosseini Akbar, Majidi Jafar, Baradaran Behzad, Yousefi Mehdi

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2015 Dec;5(Suppl 1):605-14. doi: 10.15171/apb.2015.082. Epub 2015 Dec 31.

Abstract

Human Toll-like receptors (TLRs) are a family of transmembrane receptors, which play a key role in both innate and adaptive immune responses. Beside of recognizing specific molecular patterns that associated with different types of pathogens, TLRs may also detect a number of self-proteins and endogenous nucleic acids. Activating TLRs lead to the heightened expression of various inflammatory genes, which have a protective role against infection. Data rising predominantly from human patients and animal models of autoimmune disease indicate that, inappropriate triggering of TLR pathways by exogenous or endogenous ligands may cause the initiation and/or perpetuation of autoimmune reactions and tissue damage. Given their important role in infectious and non-infectious disease process, TLRs and its signaling pathways emerge as appealing targets for therapeutics. In this review, we demonstrate how TLRs pathways could be involved in autoimmune disorders and their therapeutic application.

摘要

人类 Toll 样受体(TLR)是一类跨膜受体家族,在先天性和适应性免疫反应中均发挥关键作用。除了识别与不同类型病原体相关的特定分子模式外,TLR 还可能检测多种自身蛋白和内源性核酸。激活 TLR 会导致各种炎症基因的表达增强,这些基因对感染具有保护作用。主要来自人类患者和自身免疫性疾病动物模型的数据表明,外源性或内源性配体对 TLR 通路的不适当触发可能会导致自身免疫反应和组织损伤的启动和/或持续。鉴于 TLR 在感染性和非感染性疾病过程中的重要作用,TLR 及其信号通路成为有吸引力的治疗靶点。在本综述中,我们阐述了 TLR 通路如何参与自身免疫性疾病及其治疗应用。

相似文献

1
Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.
Adv Pharm Bull. 2015 Dec;5(Suppl 1):605-14. doi: 10.15171/apb.2015.082. Epub 2015 Dec 31.
2
Toll like receptors and autoimmunity: a critical appraisal.
J Autoimmun. 2007 Dec;29(4):310-8. doi: 10.1016/j.jaut.2007.09.001. Epub 2007 Oct 24.
3
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
Int Rev Immunol. 2018 Jan 2;37(1):20-36. doi: 10.1080/08830185.2017.1380200. Epub 2017 Oct 13.
4
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
World J Gastroenterol. 2014 Dec 21;20(47):17699-708. doi: 10.3748/wjg.v20.i47.17699.
5
Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
Pharmacol Rev. 2016 Jan;68(1):142-67. doi: 10.1124/pr.114.010090.
7
Toll-like receptors on the fork roads between innate and adaptive immunity.
Hum Immunol. 2011 Dec;72(12):1188-93. doi: 10.1016/j.humimm.2011.08.015. Epub 2011 Aug 28.
8
Toll-like receptors in inflammation of the central nervous system.
Int Immunopharmacol. 2011 Oct;11(10):1407-14. doi: 10.1016/j.intimp.2011.04.025. Epub 2011 May 18.
9
RAGE and TLRs: relatives, friends or neighbours?
Mol Immunol. 2013 Dec;56(4):739-44. doi: 10.1016/j.molimm.2013.07.008. Epub 2013 Aug 14.
10
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
Int Immunopharmacol. 2011 Oct;11(10):1422-32. doi: 10.1016/j.intimp.2011.04.026. Epub 2011 May 18.

引用本文的文献

2
Virus-Triggered Autoimmunity Was Associated With Hirschsprung's Disease Through Activation of Innate Immunity.
J Immunol Res. 2024 Oct 26;2024:4838514. doi: 10.1155/2024/4838514. eCollection 2024.
4
TLR4 induced TRPM2 mediated neuropathic pain.
Front Pharmacol. 2024 Sep 12;15:1472771. doi: 10.3389/fphar.2024.1472771. eCollection 2024.
7
New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report.
Oman Med J. 2024 Jan 31;39(4):e597. doi: 10.5001/omj.2024.06. eCollection 2024 Jan.
8
RNA Binding Proteins that Mediate LPS-induced Alternative Splicing of the MyD88 Innate Immune Regulator.
J Mol Biol. 2024 Apr 15;436(8):168497. doi: 10.1016/j.jmb.2024.168497. Epub 2024 Feb 17.
9
deficiency exacerbates lupus-like disease in the MRL/ mouse model.
Front Immunol. 2024 Jan 30;15:1359534. doi: 10.3389/fimmu.2024.1359534. eCollection 2024.
10
A systematic review of dysregulated microRNAs in Hashimoto's thyroiditis.
Endocrine. 2024 Jun;84(3):800-811. doi: 10.1007/s12020-023-03673-4. Epub 2024 Jan 12.

本文引用的文献

1
Role of toll-like receptors in multiple sclerosis.
Am J Clin Exp Immunol. 2013 Feb 27;2(1):75-93. Print 2013.
2
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
Exp Mol Med. 2013 Feb 22;45(2):e11. doi: 10.1038/emm.2013.28.
3
TLR7 and TLR9 in SLE: when sensing self goes wrong.
Immunol Res. 2012 Sep;53(1-3):58-77. doi: 10.1007/s12026-012-8270-1.
4
TLR-dependent T cell activation in autoimmunity.
Nat Rev Immunol. 2011 Nov 18;11(12):807-22. doi: 10.1038/nri3095.
5
Nucleic acid-binding polymers as anti-inflammatory agents.
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14055-60. doi: 10.1073/pnas.1105777108. Epub 2011 Aug 15.
6
B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome.
Acta Medica (Hradec Kralove). 2011;54(2):51-7. doi: 10.14712/18059694.2016.18.
7
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity.
Semin Immunol. 2011 Apr;23(2):106-12. doi: 10.1016/j.smim.2011.01.016.
8
Toll-like receptor signaling pathways--therapeutic opportunities.
Mediators Inflamm. 2010;2010:781235. doi: 10.1155/2010/781235. Epub 2010 Oct 17.
9
Targeting Toll-like receptors for treatment of SLE.
Mediators Inflamm. 2010;2010. doi: 10.1155/2010/498980. Epub 2010 Sep 19.
10
Modulation of B cell responses by Toll-like receptors.
Cell Tissue Res. 2011 Jan;343(1):131-40. doi: 10.1007/s00441-010-1031-3. Epub 2010 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验